Results 1 to 10 of about 26,249 (178)

Progressive subcortical involvement as spinocerebellar ataxia type 3 advances [PDF]

open access: yesOrphanet Journal of Rare Diseases
Background and objectives Spinocerebellar ataxia type 3 (SCA3) is a progressive neurodegenerative disease characterized by heterogeneous motor and nonmotor manifestations.
Pubing Yuan   +13 more
doaj   +4 more sources

Abnormal eye movements in spinocerebellar ataxia type 3 [PDF]

open access: yesBMC Neurology, 2021
Background Abnormal eye movements are common in spinocerebellar ataxias Type 3 (SCA3). We conducted the research to explore the frequency of abnormal eye movements in Chinese patients with SCA3, to compare the demographic and clinical characteristics ...
Junyu Lin   +9 more
doaj   +3 more sources

Supratentorial and Infratentorial Lesions in Spinocerebellar Ataxia Type 3 [PDF]

open access: yesFrontiers in Neurology, 2020
Background: Spinocerebellar ataxia type 3 (SCA) is a cerebellum-dominant degenerative disorder that is characterized primarily by infratentorial damage, although less severe supratentorial involvement may contribute to the clinical manifestation.
Po-Shan Wang   +14 more
doaj   +3 more sources

The association between diplopia and clinical phenotypes in spinocerebellar ataxia type 3 [PDF]

open access: yesBMC Neurology
Background Spinocerebellar ataxia type 3 (SCA3) is a rare monogenic hereditary neurodegenerative disease. It is the most common form of spinocerebellar ataxia worldwide, with diplopia being one of its most frequent symptoms. Diplopia has been reported to
Mei Zheng   +5 more
doaj   +2 more sources

The cerebral metabolic topography of spinocerebellar ataxia type 3

open access: yesNeuroImage: Clinical, 2018
Introduction: We aimed to uncover the pattern of network-level changes in neuronal function in Spinocerebellar ataxia type 3 (SCA3). Methods: 17 genetically-confirmed SCA3 patients and 16 controls underwent structural MRI and static resting-state [18F ...
Sanne K. Meles   +10 more
doaj   +3 more sources

IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]

open access: yesExp Ther Med
Spinocerebellar ataxia type 3 (SCA3) is a progressive neurodegenerative disorder for which reliable metabolic biomarkers are lacking. Insulin-like growth factor binding protein 1 (IGFBP1), a stress-responsive protein regulated by insulin signaling, serves as an indicator of neurodegenerative burden.
Chiu C   +8 more
europepmc   +3 more sources

Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3

open access: yesCells, 2022
Spinocerebellar ataxia type 3 (SCA3) is a neurodegenerative disorder showing progressive neuronal loss in several brain areas and a broad spectrum of motor and non-motor symptoms, including ataxia and altered sleep.
Maria-Efstratia Tsimpanouli   +6 more
doaj   +3 more sources

Fatigue in the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 3. [PDF]

open access: yesEur J Neurol
ABSTRACTObjectiveFatigue is a significant symptom in patients with spinocerebellar ataxia type 3 (SCA3). This study explores the role of fatigue in SCA3, examining its impact on quality of life and its potential as an indicator of disease progression.MethodsWe prospectively recruited 128 molecularly confirmed SCA3 patients and 125 sex‐, age‐, and ...
Chen ZL   +14 more
europepmc   +3 more sources

Genome editing in spinocerebellar ataxia type 3 cells improves Golgi apparatus structure [PDF]

open access: yesScientific Reports
Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disease caused by repeat expansion of the CAG trinucleotide within exon 10 of the ATXN3 gene.
Yanlin Wang   +8 more
doaj   +2 more sources

Split hand and minipolymyoclonus in spinocerebellar ataxia type 3: a case report [PDF]

open access: yesBMC Neurology
Background Spinocerebellar ataxia type 3 (SCA3), also known as Machado–Joseph disease, is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansion in exon 10 of ATXN3.
Anli Eki   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy